AbCellera Results Presentation Deck

Q1 2022 BUSINESS UPDATE COPYRIGHT © ABCELLERA 5 PARTNERSHIPS DEAL STRUCTURES THAT CAPTURE DOWNSTREAM VALUE We expanded our existing partnership with Empirico to 7 targets, and the new agreement provides us with the option, on a program-by- program basis, to co-invest in preclinical and clinical development in exchange for a greater ownership stake in the program. In the event we continue to co-invest, we will maintain a 50% interest in each program. EMPIRICO A NEXT GENERATION THERAPEUTICS COMPANY 7 targets multi-year Qmultiple indications

View entire presentation